These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19141562)

  • 41. Explaining trends in Scottish coronary heart disease mortality between 2000 and 2010 using IMPACTSEC model: retrospective analysis using routine data.
    Hotchkiss JW; Davies CA; Dundas R; Hawkins N; Jhund PS; Scholes S; Bajekal M; O'Flaherty M; Critchley J; Leyland AH; Capewell S
    BMJ; 2014 Feb; 348():g1088. PubMed ID: 24503058
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A systematic review and economic evaluation of statins for the prevention of coronary events.
    Ward S; Lloyd Jones M; Pandor A; Holmes M; Ara R; Ryan A; Yeo W; Payne N
    Health Technol Assess; 2007 Apr; 11(14):1-160, iii-iv. PubMed ID: 17408535
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000.
    Ford ES; Ajani UA; Croft JB; Critchley JA; Labarthe DR; Kottke TE; Giles WH; Capewell S
    N Engl J Med; 2007 Jun; 356(23):2388-98. PubMed ID: 17554120
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increasing mortality from coronary heart disease among males in Sweden.
    Welin L; Wilhelmsen L; Svärdsudd K; Larsson B; Tibblin G
    Cardiology; 1985; 72(1-2):75-80. PubMed ID: 3872176
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The impact of birth weight on coronary heart disease morbidity and mortality in a birth cohort followed up for 85 years: a population-based study of men born in 1913.
    Eriksson M; Wallander MA; Krakau I; Wedel H; Svärdsudd K
    J Intern Med; 2004 Dec; 256(6):472-81. PubMed ID: 15554948
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multivariate analyses of mortality from coronary heart disease due to biological and behavioural factors.
    Qvist J; Johansson SE; Johansson LM
    Scand J Soc Med; 1996 Mar; 24(1):67-76. PubMed ID: 8740879
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Population assessment of future trajectories in coronary heart disease mortality.
    Thorolfsdottir RB; Aspelund T; Capewell S; Critchley J; Gudnason V; Andersen K
    PLoS One; 2014; 9(1):e85800. PubMed ID: 24465713
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differences in declining mortality rates due to coronary heart disease by neighbourhood deprivation.
    Oudin Åström D; Sundquist J; Sundquist K
    J Epidemiol Community Health; 2018 Apr; 72(4):314-318. PubMed ID: 29330167
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997.
    Laatikainen T; Critchley J; Vartiainen E; Salomaa V; Ketonen M; Capewell S
    Am J Epidemiol; 2005 Oct; 162(8):764-73. PubMed ID: 16150890
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Can small changes in cardiovascular risk factors predict large future reductions in coronary heart disease mortality in Ireland?
    Kabir Z; Bennett K; Critchley JA; Capewell S
    Eur J Epidemiol; 2007; 22(2):83-9. PubMed ID: 17318337
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CHD in Sweden: mortality, incidence and risk factors over 20 years in Gothenburg.
    Wilhelmsen L; Johansson S; Ulvenstam G; Welin L; Rosengren A; Eriksson H; Larsson B; Tsipogianni A; Wedel H
    Int J Epidemiol; 1989; 18(3 Suppl 1):S101-8. PubMed ID: 2807689
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Contrasting cardiovascular mortality trends in Eastern Mediterranean populations: Contributions from risk factor changes and treatments.
    Critchley J; Capewell S; O'Flaherty M; Abu-Rmeileh N; Rastam S; Saidi O; Sözmen K; Shoaibi A; Husseini A; Fouad F; Ben Mansour N; Aissi W; Ben Romdhane H; Unal B; Bandosz P; Bennett K; Dherani M; Al Ali R; Maziak W; Arık H; Gerçeklioğlu G; Altun DU; Şimşek H; Doganay S; Demiral Y; Aslan Ö; Unwin N; Phillimore P; ; ; Achour N; Aissi W; Allani R; Arfa C; Abu-Kteish H; Abu-Rmeileh N; Al Ali R; Altun D; Ahmad B; Arık H; Aslan Ö; Beltaifa L; Ben Mansour N; Bennett K; Ben Romdhane H; Ben Salah N; Collins M; Critchley J; Capewell S; Dherani M; Demiral Y; Doganay S; Elias M; Ergör G; Fadhil I; Fouad F; Gerçeklioğlu G; Ghandour R; Göğen S; Husseini A; Jaber S; Kalaca S; Khatib R; Khatib R; Koudsie S; Kilic B; Lassoued O; Mason H; Maziak W; Mayaleh MA; Mikki N; Moukeh G; Flaherty MO; Phillimore P; Rastam S; Roglic G; Saidi O; Saatli G; Satman I; Shoaibi A; Şimşek H; Soulaiman N; Sözmen K; Tlili F; Unal B; Unwin N; Yardim N; Zaman S
    Int J Cardiol; 2016 Apr; 208():150-61. PubMed ID: 26878275
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potential benefits of healthy food and lifestyle policies for reducing coronary heart disease mortality in Turkish adults by 2025: a modelling study.
    Sahan C; Sozmen K; Unal B; O'Flaherty M; Critchley J
    BMJ Open; 2016 Jul; 6(7):e011217. PubMed ID: 27388358
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adverse risk factor trends limit gains in coronary heart disease mortality in Barbados: 1990-2012.
    Sobers NP; Unwin N; Samuels TA; Capewell S; O'Flaherty M; Critchley JA
    PLoS One; 2019; 14(4):e0215392. PubMed ID: 30995272
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.
    Kones R
    Drug Des Devel Ther; 2011; 5():325-80. PubMed ID: 21792295
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Coronary heart disease prevention in clinical practice: are patients with diabetes special? Evidence from two studies of older men and women.
    Emberson JR; Whincup PH; Lawlor DA; Montaner D; Ebrahim S
    Heart; 2005 Apr; 91(4):451-5. PubMed ID: 15772196
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Explaining the fall in Coronary Heart Disease mortality in the Republic of Ireland between 2000 and 2015 - IMPACT modelling study.
    Marasigan V; Perry I; Bennett K; Balanda K; Capewell S; O' Flaherty M; Kabir Z
    Int J Cardiol; 2020 Jul; 310():159-161. PubMed ID: 32276770
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Explaining the Decline in Coronary Heart Disease Mortality in the Netherlands between 1997 and 2007.
    Koopman C; Vaartjes I; van Dis I; Verschuren WM; Engelfriet P; Heintjes EM; Blokstra A; Deeg DJ; Visser M; Bots ML; O'Flaherty M; Capewell S
    PLoS One; 2016; 11(12):e0166139. PubMed ID: 27906998
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Trends in age-specific coronary heart disease mortality in the European Union over three decades: 1980-2009.
    Nichols M; Townsend N; Scarborough P; Rayner M
    Eur Heart J; 2013 Oct; 34(39):3017-27. PubMed ID: 23801825
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Does high intelligence improve prognosis? The association of intelligence with recurrence and mortality among Swedish men with coronary heart disease.
    Sörberg Wallin A; Falkstedt D; Allebeck P; Melin B; Janszky I; Hemmingsson T
    J Epidemiol Community Health; 2015 Apr; 69(4):347-53. PubMed ID: 25488976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.